The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma DJ Pinato, R Sharma, E Allara, C Yen, T Arizumi, K Kubota, D Bettinger, ... Journal of hepatology 66 (2), 338-346, 2017 | 384 | 2017 |
Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer—a phase 1 study TS Uldrick, PH Gonçalves, M Abdul-Hay, AJ Claeys, B Emu, MS Ernstoff, ... JAMA oncology 5 (9), 1332-1339, 2019 | 216 | 2019 |
Precision medicine from a public health perspective R Ramaswami, R Bayer, S Galea Annual Review of Public Health 39 (1), 153-168, 2018 | 190 | 2018 |
Discovery of Kaposi’s sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA T Tagawa, S Gao, VN Koparde, M Gonzalez, JL Spouge, AP Serquiña, ... Proceedings of the National Academy of Sciences 115 (50), 12805-12810, 2018 | 160 | 2018 |
Viral, immunologic, and clinical features of primary effusion lymphoma K Lurain, MN Polizzotto, K Aleman, M Bhutani, KM Wyvill, PH Gonçalves, ... Blood, The Journal of the American Society of Hematology 133 (16), 1753-1761, 2019 | 125 | 2019 |
68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours R Sharma, WM Wang, S Yusuf, J Evans, R Ramaswami, F Wernig, ... Radiotherapy and Oncology 141, 108-115, 2019 | 92 | 2019 |
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours FEM Froeling, R Ramaswami, P Papanastasopoulos, B Kaur, NJ Sebire, ... British journal of cancer 120 (6), 587-594, 2019 | 77 | 2019 |
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy TS Uldrick, SV Adams, R Fromentin, M Roche, SP Fling, PH Gonçalves, ... Science translational medicine 14 (629), eabl3836, 2022 | 73 | 2022 |
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases R Ramaswami, K Lurain, MN Polizzotto, I Ekwede, K Waldon, ... Blood Advances 5 (6), 1660-1670, 2021 | 61 | 2021 |
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis R Ramaswami, MD Villarreal, DM Pitta, JS Carpenter, J Stebbing, ... Breast cancer research and treatment 152, 231-237, 2015 | 58 | 2015 |
On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study J Howell, DJ Pinato, R Ramaswami, D Bettinger, T Arizumi, C Ferrari, ... Alimentary pharmacology & therapeutics 45 (8), 1146-1155, 2017 | 53 | 2017 |
Peptide receptor radionuclide therapy for metastatic paragangliomas DJ Pinato, JRM Black, R Ramaswami, TM Tan, D Adjogatse, R Sharma Medical oncology 33, 1-5, 2016 | 49 | 2016 |
Oncologic treatment of HIV-associated Kaposi sarcoma 40 years on R Ramaswami, K Lurain, R Yarchoan Journal of Clinical Oncology 40 (3), 294-306, 2022 | 48 | 2022 |
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma K Lurain, R Ramaswami, R Mangusan, A Widell, I Ekwede, J George, ... Journal for immunotherapy of cancer 9 (2), 2021 | 48 | 2021 |
The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development DJ Pinato, C Yen, D Bettinger, R Ramaswami, T Arizumi, C Ward, M Pirisi, ... Alimentary pharmacology & therapeutics 45 (5), 714-722, 2017 | 47 | 2017 |
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease R Ramaswami, K Lurain, CJ Peer, A Serquiña, V Wang, A Widell, ... Blood, The Journal of the American Society of Hematology 135 (25), 2316-2319, 2020 | 46 | 2020 |
Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA M Gruffaz, T Zhang, V Marshall, P Gonçalves, R Ramaswami, N Labo, ... PLoS pathogens 16 (1), e1008114, 2020 | 44 | 2020 |
delivering precision oncology in intermediate‐stage liver cancer DJ Pinato, J Howell, R Ramaswami, R Sharma Alimentary pharmacology & therapeutics 45 (12), 1514-1523, 2017 | 42 | 2017 |
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib JA Howell, DJ Pinato, R Ramaswami, T Arizumi, C Ferrari, A Gibbin, ... Oncotarget 8 (22), 36161, 2017 | 41 | 2017 |
‘Being there’for women with metastatic breast cancer: a pan-European patient survey V Harding, M Afshar, J Krell, R Ramaswami, CJ Twelves, J Stebbing British journal of cancer 109 (6), 1543-1548, 2013 | 41 | 2013 |